Leadership Overview
Johnson & Johnson Services Inc has 10 executives leading key functions including strategy, finance, human resources, information technology, and revenue generation.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and devices to healthcare providers and patients globally across critical areas like oncology and cardiovascular care.
Driven by a commitment to innovation, Johnson & Johnson Services Inc develops pharmaceuticals and medical technologies, providing essential medicines and devices to healthcare providers and patients globally across critical areas like oncology and cardiovascular care.
Leadership Roles at Johnson & Johnson Services Inc
Joaquin Duato - Chief Executive Officer
Joaquin Duato, the Chief Executive Officer at Johnson & Johnson Services Inc, directs the company's overarching strategy and global operations. This leadership role involves guiding the development and delivery of innovative pharmaceuticals and medical technologies, ensuring alignment with the company's mission to advance health for humanity. Duato oversees the integration of diverse business segments, fostering a culture of scientific excellence and patient-centricity. The Chief Executive Officer's responsibilities extend to shaping market impact through strategic investments and partnerships, particularly in critical areas such as oncology, immunology, neuroscience, and cardiovascular care. By driving operational efficiency and long-term growth, Joaquin Duato ensures Johnson & Johnson Services Inc maintains its position as a leading global healthcare provider, serving healthcare professionals and patients worldwide with essential medical solutions.
Davide Miksa - Chief Financial Officer & Vice President, Finance, Johnson & Johnson Innovative Medicine (Japan)
Davide Miksa, the Chief Financial Officer & Vice President, Finance, Johnson & Johnson Innovative Medicine (Japan) at Johnson & Johnson Services Inc, manages the financial operations and strategic fiscal planning for the Innovative Medicine division within Japan. This critical role involves overseeing all financial aspects, including budgeting, forecasting, and financial reporting, to support the division's growth and profitability objectives. Miksa ensures robust financial controls and compliance with local and global regulations, safeguarding the company's assets and financial integrity. The Chief Financial Officer's purview includes analyzing market trends and economic conditions to inform investment decisions and optimize resource allocation for pharmaceutical development and commercialization efforts. By providing strategic financial guidance, Davide Miksa directly contributes to the successful execution of Johnson & Johnson's mission to deliver innovative medicines to patients in the Japanese market.
Lauren Johnson - Chief Financial Officer, External Innovation Finance
Lauren Johnson, the Chief Financial Officer, External Innovation Finance at Johnson & Johnson Services Inc, spearheads the financial management and strategic investment analysis for the company's external innovation initiatives. This position requires rigorous financial oversight of partnerships, acquisitions, and collaborations aimed at identifying and integrating cutting-edge pharmaceuticals and medical technologies. Johnson evaluates the financial viability of potential investments, ensuring alignment with Johnson & Johnson's long-term growth strategy and commitment to advancing healthcare solutions. The Chief Financial Officer's responsibilities include developing financial models, conducting due diligence, and managing the financial integration of new ventures. By providing critical financial expertise, Lauren Johnson supports the company's pursuit of novel treatments and medical devices that address unmet patient needs globally.
Stephen Tremel - Business Operations Chief Financial Officer & Vice President
Stephen Tremel, the Business Operations Chief Financial Officer & Vice President at Johnson & Johnson Services Inc, manages the financial operations and strategic planning for the company's business operations. This key role involves overseeing budgeting, financial analysis, and resource allocation to ensure operational efficiency and profitability across various business units. Tremel provides critical financial insights to support decision-making, driving cost optimization and revenue enhancement initiatives. The Chief Financial Officer's responsibilities include developing financial models, forecasting performance, and ensuring compliance with financial regulations. By maintaining rigorous financial discipline and strategic oversight, Stephen Tremel supports Johnson & Johnson Services Inc's commitment to delivering innovative healthcare solutions while ensuring sustainable business growth.
Kristen Mulholland - Chief Human Resources Officer & Executive VP
Kristen Mulholland, the Chief Human Resources Officer & Executive VP at Johnson & Johnson Services Inc, directs global human capital strategy and organizational development. This executive leadership position encompasses talent acquisition, retention, employee engagement, and fostering a diverse and inclusive workplace culture across all business segments. Mulholland oversees the implementation of HR policies and programs that support the company's mission of advancing health and well-being worldwide. The Chief Human Resources Officer's responsibilities include aligning workforce capabilities with strategic business objectives, ensuring the development of leadership pipelines, and managing compensation and benefits programs. By championing employee growth and well-being, Kristen Mulholland ensures that Johnson & Johnson Services Inc possesses the skilled and motivated workforce necessary to drive innovation in pharmaceuticals and medical technologies.
Danielle Gomes - Chief Information Officer, J & J Medtech LATAM
Danielle Gomes, the Chief Information Officer, J & J Medtech LATAM at Johnson & Johnson Services Inc, leads the information technology strategy and operations for the Medical Technology segment across Latin America. This role involves architecting and implementing robust IT infrastructure and digital solutions to support Medtech business objectives, including product development, manufacturing, and commercialization. Gomes ensures the security and reliability of IT systems, driving digital transformation initiatives to enhance operational efficiency and customer engagement within the region. The Chief Information Officer's focus includes leveraging technology to improve patient outcomes and support healthcare providers through innovative medical devices and surgical products. By overseeing technology adoption and integration, Danielle Gomes plays a vital part in advancing Johnson & Johnson's healthcare mission throughout Latin America.
Jeff Srour - Worldwide, Medtech Vice President & Chief Information Officer
Jeff Srour, the Worldwide, Medtech Vice President & Chief Information Officer at Johnson & Johnson Services Inc, directs global information technology strategy and execution for the Medical Technology sector. This comprehensive role involves overseeing the development and deployment of advanced digital solutions, data analytics, and IT infrastructure to support Medtech innovation, manufacturing, and commercial operations on a global scale. Srour ensures the cybersecurity and operational resilience of all Medtech IT systems, driving digital transformation to enhance product development and customer experience. The Chief Information Officer's mandate includes fostering technological advancements that improve surgical procedures and patient care, aligning IT capabilities with the company's mission to provide cutting-edge medical devices. Through strategic technology leadership, Jeff Srour enables Johnson & Johnson Services Inc to deliver transformative healthcare solutions worldwide.
Lynn Gorham - Director, Programmatic Chief Revenue Officer
Lynn Gorham, the Director, Programmatic Chief Revenue Officer at Johnson & Johnson Services Inc, drives revenue generation through strategic programmatic initiatives. This role focuses on optimizing advertising and marketing technology platforms to enhance customer engagement and drive sales across the company's diverse product portfolio. Gorham oversees the implementation of data-driven strategies to maximize return on investment for digital marketing campaigns, ensuring efficient allocation of resources. The Chief Revenue Officer's responsibilities include analyzing market performance, identifying new revenue streams, and fostering cross-functional collaboration to achieve ambitious sales targets. By leading programmatic revenue efforts, Lynn Gorham contributes significantly to Johnson & Johnson Services Inc's market presence and financial growth in the competitive healthcare landscape.
Ko Katsuragi - Manager, Medical Affairs, Chief Marketing Officer Office
Ko Katsuragi, the Manager, Medical Affairs, Chief Marketing Officer Office at Johnson & Johnson Services Inc, supports strategic marketing initiatives within the Medical Affairs division. This position involves coordinating cross-functional teams to ensure alignment between medical insights and marketing strategies, particularly concerning pharmaceuticals and medical technologies. Katsuragi contributes to the development of communication plans and educational materials that effectively convey the value of Johnson & Johnson's innovative healthcare solutions to medical professionals and stakeholders. The Manager's role within the Chief Marketing Officer Office requires a deep understanding of the healthcare landscape and the ability to translate complex scientific information into compelling market messaging. By bridging medical expertise and marketing strategy, Ko Katsuragi enhances the reach and impact of Johnson & Johnson's offerings.
Keith McKune - Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability )
Keith McKune, the Senior Scientist & Chief Revenue Officer, Analytical (Release & Stability ) at Johnson & Johnson Services Inc, combines scientific expertise with revenue generation responsibilities for analytical services related to product release and stability testing. This unique role involves overseeing the scientific integrity and commercial success of analytical testing operations, ensuring products meet stringent quality and regulatory standards before market release. McKune drives business development efforts within the analytical services domain, identifying opportunities to expand revenue streams and enhance client relationships. The Chief Revenue Officer's focus includes optimizing laboratory processes, ensuring timely and accurate analytical results, and contributing to the overall quality assurance framework. By integrating scientific rigor with commercial acumen, Keith McKune supports Johnson & Johnson Services Inc's commitment to delivering safe and effective healthcare products.
Explore Leadership Teams in Manufacturing
Unither Pharmaceuticals is a global contract development and manufacturing organization (CDMO) specializing in the production of single-dose liquid pharmaceuticals and sterile unit-dose formats for the pharmaceutical and consumer healthcare industries. The company is recognized as a world leader in blow-fill-seal technology, an advanced aseptic manufacturing process that forms, fills, and seals plastic containers in a continuous automated operation, ensuring high levels of sterility and product integrity. Unither's expertise encompasses the development and manufacturing of various liquid dosage forms including oral solutions, suspensions, nasal sprays, eye drops, and other sterile and non-sterile pharmaceutical products delivered in innovative single-dose formats. The company serves a diverse client base of pharmaceutical companies, biotechnology firms, and consumer health brands, providing comprehensive services from formulation development and clinical trial manufacturing to commercial-scale production and packaging. With manufacturing facilities strategically located across multiple continents including Europe and North America, Unither maintains strict quality standards and regulatory compliance with international pharmaceutical guidelines including FDA and EMA requirements. The company emphasizes innovation in drug delivery systems, patient convenience, and sustainability while helping clients bring their pharmaceutical products to market efficiently through its specialized manufacturing capabilities and technical expertise in unit-dose liquid formulations.
Company Leadership HH
JK
MC
MB
Eisai Co., Ltd. offers pharmaceutical products in Japan. It offers Aricept for the treatment of alzheimer's disease/dementia with Lewy bodies; Methycobal for the treatment of peripheral neuropathy; and Fycompa, an antiepileptic drug for the adjunctive treatment of partial-onset and primary generalized tonic-clonic seizures. The company also provides Lyrica for pain treatment; Dayvigo, an anti-insomnia drug for the treatment of adults with insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; and Halaven, an anticancer agent/microtubule dynamics inhibitor for the treatment of breast cancer and liposarcoma. In addition, it offers Pariet, a proton-pump inhibitor for the treatment of gastric and duodenal ulcers, reflux esophagitis, and eradication of Helicobacter pylori infections, etc.; Humira, a fully human anti-TNF-a monoclonal antibody for the treatment of autoimmune diseases, such as rheumatoid arthritis; and Chocola BB plus, a vitamin B2 preparation for rough skin and stomatitis, as well as various products, which include third-class OTC drugs, designated quasi-drugs, and food with nutrient function. The company was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.
Company Leadership TI
JS
MD
Zai Lab functions as a bio-pharmaceutical and drug discovery company with a focus in oncology and autoimmune diseases. The company was established in 2014 and is headquartered out of Shanghai, China.
Company Leadership KL
XW
DL
HR
Jamjoom Pharma is one of the leading pharmaceutical companies in the Afrasia region focused on the Middle East, Africa, and CIS countries. Based in Jeddah, Saudi Arabia, Jamjoom Pharma manufactures and markets pharmaceutical products, over the counter (OTC) medicines, and health related consumer products. The company is owned by the Jamjoom Group.
Company Leadership TH
NS
AM
AH
Frequently Asked Questions Regarding Johnson & Johnson Services Inc Top Executives and Leadership Team
